<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen B</submitter><funding>the Social Development Foundation of Zhenjiang</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Hunan Province</funding><funding>Natural Science Foundation of Jiangsu Province</funding><pagination>545</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8525017</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Papillary renal cell carcinoma (pRCC) ranks second in renal cell carcinoma and the prognosis of pRCC remains poor. Here, we aimed to screen and identify a novel prognostic cancer-related lncRNA signature in pRCC.&lt;h4>Methods&lt;/h4>The RNA-seq profile and clinical feature of pRCC cases were downloaded from TCGA database. Significant cancer-related lncRNAs were obtained from the Immlnc database. Differentially expressed cancer-related lncRNAs (DECRLs) in pRCC were screened for further analysis. Cox regression report was implemented to identify prognostic cancer-related lncRNAs and establish a prognostic risk model, and ROC curve analysis was used to evaluate its precision. The correlation between RP11-63A11.1 and clinical characteristics was further analyzed. Finally, the exp</pubmed_abstract><journal>Cancer cell international</journal><pubmed_title>A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma.</pubmed_title><pmcid>PMC8525017</pmcid><funding_grant_id>2019JJ40269</funding_grant_id><funding_grant_id>SH2021033</funding_grant_id><funding_grant_id>BK20211123</funding_grant_id><funding_grant_id>81402100</funding_grant_id><pubmed_authors>Dong D</pubmed_authors><pubmed_authors>Zou Y</pubmed_authors><pubmed_authors>Hu W</pubmed_authors><pubmed_authors>Yao Q</pubmed_authors><pubmed_authors>Chen B</pubmed_authors></additional><is_claimable>false</is_claimable><name>A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma.</name><description>&lt;h4>Background&lt;/h4>Papillary renal cell carcinoma (pRCC) ranks second in renal cell carcinoma and the prognosis of pRCC remains poor. Here, we aimed to screen and identify a novel prognostic cancer-related lncRNA signature in pRCC.&lt;h4>Methods&lt;/h4>The RNA-seq profile and clinical feature of pRCC cases were downloaded from TCGA database. Significant cancer-related lncRNAs were obtained from the Immlnc database. Differentially expressed cancer-related lncRNAs (DECRLs) in pRCC were screened for further analysis. Cox regression report was implemented to identify prognostic cancer-related lncRNAs and establish a prognostic risk model, and ROC curve analysis was used to evaluate its precision. The correlation between RP11-63A11.1 and clinical characteristics was further analyzed. Finally, the exp</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-22T11:27:39.79Z</modification><creation>2025-04-05T23:56:02.581Z</creation></dates><accession>S-EPMC8525017</accession><cross_references><pubmed>34663322</pubmed><doi>10.1186/s12935-021-02247-6</doi></cross_references></HashMap>